The Hematology Cancer Patient Experience of "Facing Death" in the Last Year of Life: A Constructivist Grounded Theory Study.

IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY
Clinical Neuropharmacology Pub Date : 2024-03-01 Epub Date: 2022-12-11 DOI:10.1097/NCC.0000000000001180
Karen Campbell, Fiona Harris, Kathleen Stoddart
{"title":"The Hematology Cancer Patient Experience of \"Facing Death\" in the Last Year of Life: A Constructivist Grounded Theory Study.","authors":"Karen Campbell, Fiona Harris, Kathleen Stoddart","doi":"10.1097/NCC.0000000000001180","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>For hematology cancer patients, the process of dying is described as \"troublesome.\" Qualitative studies have focused on views of healthcare professionals and caregiver stakeholders. To date, there have been no studies from the patient's perspective on facing death while in the last year of life.</p><p><strong>Objective: </strong>The aim of this study was to develop an understanding of the hematology cancer patient's experience of the process of dying in the last year of life.</p><p><strong>Methods: </strong>The study method was constructivist grounded theory using semistructured interviews, a constant comparison technique, and memoing to collection and analysis of data. The 21 participants were attending a UK cancer center, a cancer unit, or a hospice.</p><p><strong>Results: </strong>This article describes 1 core category within the incurable hematology cancer illness trajectory through 4 subcategories: transitional phase, chronic phase, dying phase, and liminal phase.</p><p><strong>Conclusion: </strong>This unique study illustrates that, although life can be prolonged, \"facing death\" still occurs upon hospitalization and relapse regularly over the illness trajectory.</p><p><strong>Implications for practice: </strong>It is important that clinical practice acknowledges those participants in an incurable illness trajectory while living are focused on avoiding death rather than the ability to cure the disease. Services need to be responsive to the ambiguity of both living and dying by providing holistic management simultaneously, especially after critical episodes of care, to enhance the process of care in the last year of life, and assessment should incorporate the discussion of experiencing life-threatening events.</p>","PeriodicalId":10449,"journal":{"name":"Clinical Neuropharmacology","volume":" ","pages":"132-140"},"PeriodicalIF":0.8000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/NCC.0000000000001180","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: For hematology cancer patients, the process of dying is described as "troublesome." Qualitative studies have focused on views of healthcare professionals and caregiver stakeholders. To date, there have been no studies from the patient's perspective on facing death while in the last year of life.

Objective: The aim of this study was to develop an understanding of the hematology cancer patient's experience of the process of dying in the last year of life.

Methods: The study method was constructivist grounded theory using semistructured interviews, a constant comparison technique, and memoing to collection and analysis of data. The 21 participants were attending a UK cancer center, a cancer unit, or a hospice.

Results: This article describes 1 core category within the incurable hematology cancer illness trajectory through 4 subcategories: transitional phase, chronic phase, dying phase, and liminal phase.

Conclusion: This unique study illustrates that, although life can be prolonged, "facing death" still occurs upon hospitalization and relapse regularly over the illness trajectory.

Implications for practice: It is important that clinical practice acknowledges those participants in an incurable illness trajectory while living are focused on avoiding death rather than the ability to cure the disease. Services need to be responsive to the ambiguity of both living and dying by providing holistic management simultaneously, especially after critical episodes of care, to enhance the process of care in the last year of life, and assessment should incorporate the discussion of experiencing life-threatening events.

血液癌症患者在生命最后一年 "面对死亡 "的体验:建构主义基础理论研究。
背景:对于血液肿瘤患者来说,死亡过程被描述为 "麻烦"。定性研究主要关注医护人员和护理人员的观点。迄今为止,还没有从患者的角度研究他们在生命的最后一年面对死亡时的感受:本研究旨在了解血液肿瘤患者在生命最后一年面对死亡过程的体验:研究方法是建构主义基础理论,采用半结构式访谈、持续比较技术和备忘录来收集和分析数据。21名参与者均在英国癌症中心、癌症病房或临终关怀机构就诊:本文通过过渡阶段、慢性阶段、垂死阶段和边缘阶段等 4 个子类别,描述了无法治愈的血液癌症疾病轨迹中的 1 个核心类别:这项独特的研究说明,虽然生命可以延长,但 "面对死亡 "仍然会在住院时发生,并且在疾病轨迹中定期复发:重要的是,临床实践应认识到那些身患不治之症的参与者在生活中关注的是避免死亡,而不是治愈疾病的能力。服务机构需要同时提供整体管理,以应对生与死的模糊性,尤其是在关键护理事件发生后,以加强生命最后一年的护理过程,评估中应纳入关于经历危及生命事件的讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neuropharmacology
Clinical Neuropharmacology 医学-临床神经学
CiteScore
1.20
自引率
10.00%
发文量
63
审稿时长
6-12 weeks
期刊介绍: Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense. Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms. The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor. A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信